DETROIT – Two Parkinson’s disease studies led by Peter A. LeWitt, M.D., director of movement disorders at Henry Ford Health System, were among the top 19 presentations honored at the recent International Congress of Parkinson’s Disease and Movement Disorders meeting.
These presentations were selected out of 1,473 meeting abstracts and posters for the special Blue Ribbon session at the Congress.
A panel of experts selected these presentations for highlighting leading meeting findings with respect to relevance, novelty and quality of both clinical and basic research.
Dr. LeWitt’s presentations chosen for the 2015 Blue Ribbon Highlights are:
- “Metabolomic biospecimen analysis for measuring Parkinson’s disease progression,” featured in the category of biomarkers.
- “Inhaled levodopa (CVT-301) provides rapid improvement of OFF states in Parkinson’s disease,” featured in the category of new therapies.
More than 3,500 physicians and medical professionals from more than 80 countries attended the International Congress of Parkinson's Disease and Movement Disorders, where Dr. LeWitt also provided lectures on current newly-developed Parkinson’s disease therapies.
Krista Hopson Boyer